{"entity":{"id":"nct07108114","kind":"trial","name":"SLV-324 Treatment of Metastatic Solid Tumors","aka":[],"tldr":"A phase 1 trial of SLV-324 run by Solve Therapeutics, now recruiting.","summary":"SLV-324 Treatment of Metastatic Solid Tumors is a phase 1 interventional study registered as NCT07108114 by Solve Therapeutics, with 70 participants planned, started 2025-08-25. Conditions recorded: Metastatic Solid Tumors. Interventions recorded: SLV-324 intravenous (IV infusion).","status":"recruiting","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT07108114","url":"https://clinicaltrials.gov/study/NCT07108114"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["slv-324"],"companies":["solve-therapeutics"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07108114","phase":"1","setting":"A Phase 1 Dose-Escalation Study of SLV-324 in Subjects With Metastatic Solid Tumors","sponsor":"Solve Therapeutics","enrolled":70,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07108114/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"drug":[{"id":"slv-324","kind":"drug","name":"SLV-324","route":"/drugs/slv-324/"}],"company":[{"id":"solve-therapeutics","kind":"company","name":"Solve Therapeutics","route":"/companies/solve-therapeutics/"}]}}